Skip to content
Subscriber Only

Moderna's Patents Probed by U.S. Defense Department, FT Says

Updated on

Moderna Inc.’s patents that were filed or awarded are being probed by the U.S. Department of Defense’s research arm, the Financial Times reported, saying the company failed to disclose government funding as required by federal law.

Knowledge Ecology International, a patient advocacy group, said in a report this week that researchers didn’t disclose in vaccine patents where they got about $25 million in grants from the department’s Defense Advanced Research Projects Agency, or Darpa, for its vaccine technology, the newspaper said.